glp-1 non responders Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review non responder to glp 1
Description
10.1056/NEJMoa2312323 N
This data is invaluable for troubleshooting and for conversations with your provider about dose adjustments
By weeks 5-8, strength should be holding steady or increasing while body weight drops - which means you're losing fat and keeping muscle
Send your questions to [email protected]
